Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a year ago

Possible Interaction: Cardiac Glycosides and Quinidine

supplement:

Quinidine

Research Papers that Mention the Interaction

Quinidine, the extroisomer of quinine, was first used by Frey in 1918 in he conversion of atrial fibrillation to sinus rhythm, and it as quickly appreciated that quinidine could prolong the T interval and provoke dangerous ventricular arrhythmias, specially in the presence of a cardiac glycoside.
Heart rhythm  •  2010  |  View Paper
Because digoxin toxicity is frequently associated with severe morbidity and mortality, close monitoring of clinical and laboratory signs are mandatory whenever the cardiac glycoside is coadministered with quinidine , verapamil, amiodarone, nifedipine, and indomethacin.
Pediatrics  •  1985  |  View Paper
Evidence has been obtained that quinidine is capable of decreasing the affinity for digoxin of cardiac glycoside receptor sites on purified Na,K-ATPase and on intact human erythrocyte membranes.
The Journal of clinical investigation  •  1981  |  View Paper
A concentration dependent inhibition of the cellular uptake of both cardiac glycosides by quinine and quinidine was found, quinine being a more potent inhibitor than quinidine.
Journal of pharmaceutical sciences  •  1998  |  View Paper
It is suggested that quinidine reduces the extrarenal clearance of digoxin at least in part by inhibiting the intestinal secretion of this glycoside.
Biopharmaceutics & drug disposition  •  1984  |  View Paper
Quinidine causes a marked increase in plasma digoxin concentration in patients receiving the glycoside.
The Journal of pharmacology and experimental therapeutics  •  1981  |  View Paper
Quinidine has been shown to alter pharmacokinetics of digoxin by displacing the glycoside from mutual binding sites which are stereospecific with respect to quinidine.
The Journal of pharmacology and experimental therapeutics  •  1981  |  View Paper